SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-039754
Filing Date
2023-08-08
Accepted
2023-08-08 16:01:02
Documents
63
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q enta-20230630.htm   iXBRL 10-Q 2433143
2 EX-31.1 enta-ex31_1.htm EX-31.1 13730
3 EX-31.2 enta-ex31_2.htm EX-31.2 13721
4 EX-32.1 enta-ex32_1.htm EX-32.1 15737
5 GRAPHIC img216039289_0.jpg GRAPHIC 80226
  Complete submission text file 0000950170-23-039754.txt   8726562

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT enta-20230630.xsd EX-101.SCH 43497
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT enta-20230630_def.xml EX-101.DEF 174518
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT enta-20230630_pre.xml EX-101.PRE 306191
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT enta-20230630_cal.xml EX-101.CAL 45373
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT enta-20230630_lab.xml EX-101.LAB 375145
57 EXTRACTED XBRL INSTANCE DOCUMENT enta-20230630_htm.xml XML 1722540
Mailing Address 500 ARSENAL STREET WATERTOWN MA 02472
Business Address 500 ARSENAL STREET WATERTOWN MA 02472 617 607 0800
ENANTA PHARMACEUTICALS INC (Filer) CIK: 0001177648 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-35839 | Film No.: 231151043
SIC: 2834 Pharmaceutical Preparations